ACE inhibitor pathway (Bos taurus)

From WikiPathways

Revision as of 15:28, 30 June 2015 by Mkutmon (Talk | contribs)
Jump to: navigation, search
711EDHFBlood vesselsMesangial cells aroundblood vessels in the kidneysZona glomerulosa of the adrenal glandAng 1-7TGFB1MAS1AGTR1Angiotensin IProstacyclinDeoxycorticosteroneNR3C2AGTR2ACE2AldosteroneCYP11B1Ang 1-9ACE InhibitorKNG1AGTACEBDKRB2CMA1Angiotensin IITFsNOS3BDKRB1CTSGTFsBradykininCa++RENATP6AP2Ang 1-5ACE2251062, 8991ACEACE2


Description

The core of this pathway was elucidated over a century ago and involves the conversion of angiotensinogen to angiotensin I (Ang I) by renin, its subsequent conversion to angiotensin II (Ang II) by angiotensin converting enzyme. Ang II activates the angiotensin II receptor type 1 to induce aldosterone synthesis, increasing water and salt resorption and potassium excretion in the kidney and increasing blood pressure. Source: PharmGKB (http://www.pharmgkb.org/do/serve?objId=PA2023&objCls=Pathway)

Comments

HomologyConvert 
This pathway was inferred from Homo sapiens pathway WP554 with a 77% conversion rate.

Try the New WikiPathways

View approved pathways at the new wikipathways.org.

Quality Tags

Ontology Terms

 

Bibliography

View all...
  1. Hamming I, Cooper ME, Haagmans BL, Hooper NM, Korstanje R, Osterhaus AD, Timens W, Turner AJ, Navis G, van Goor H; ''The emerging role of ACE2 in physiology and disease.''; J Pathol, 2007 PubMed Europe PMC Scholia
  2. Athyros VG, Mikhailidis DP, Kakafika AI, Tziomalos K, Karagiannis A; ''Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?''; Expert Opin Pharmacother, 2007 PubMed Europe PMC Scholia
  3. Ferreira AJ, Raizada MK; ''Are we poised to target ACE2 for the next generation of antihypertensives?''; J Mol Med, 2008 PubMed Europe PMC Scholia
  4. Bassett MH, White PC, Rainey WE; ''The regulation of aldosterone synthase expression.''; Mol Cell Endocrinol, 2004 PubMed Europe PMC Scholia
  5. McDowell SE, Coleman JJ, Ferner RE; ''Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine.''; BMJ, 2006 PubMed Europe PMC Scholia
  6. Maron BA, Leopold JA; ''Mineralocorticoid receptor antagonists and endothelial function.''; Curr Opin Investig Drugs, 2008 PubMed Europe PMC Scholia
  7. Batenburg WW, Jan Danser AH; ''The (pro)renin receptor: a new addition to the renin-angiotensin system?''; Eur J Pharmacol, 2008 PubMed Europe PMC Scholia
  8. Weir MR; ''Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?''; Clin Ther, 2007 PubMed Europe PMC Scholia
  9. Schwartz GL, Turner ST; ''Pharmacogenetics of antihypertensive drug responses.''; Am J Pharmacogenomics, 2004 PubMed Europe PMC Scholia
  10. Huang Y, Wongamorntham S, Kasting J, McQuillan D, Owens RT, Yu L, Noble NA, Border W; ''Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms.''; Kidney Int, 2006 PubMed Europe PMC Scholia

History

View all...
CompareRevisionActionTimeUserComment
117471view10:58, 21 May 2021EweitzModified title
105956view11:48, 16 August 2019MaintBotHMDB identifier normalization
96331view09:34, 8 March 2018Mkutmonremove redundant ontology tag
96330view09:34, 8 March 2018MkutmonOntology Term : 'angiotensin signaling pathway' added !
96329view09:33, 8 March 2018MkutmonUpdated homology conversion
80846view15:28, 30 June 2015Mkutmonhomology conversion
79145view05:51, 5 March 2015KhanspersModified title
79144view05:42, 5 March 2015KhanspersUpdated conversion from Hs
71401view19:00, 17 October 2013MaintBotAutomated update of data sources
67016view09:53, 26 June 2013Christine ChichesterOntology Term : 'ACE inhibitor drug pathway' added !
63332view21:13, 9 May 2013MaintBotUpdated to 2013 gpml schema
57076view20:11, 20 January 2013Egonw
40511view19:29, 1 March 2011MaintBotRemoved redundant pathway information and comments
35048view09:36, 11 February 2010Thomasremoved genmapp notes (invalid link)
35040view09:29, 11 February 2010ThomasModified description
33754view23:59, 8 December 2009MaintBotAutomatic update of empty xrefs
31672view11:42, 14 August 2009MaintBotFixed group labels
30602view22:16, 29 July 2009MaintBotNew pathway

External references

DataNodes

View all...
NameTypeDatabase referenceComment
ACE InhibitorMetaboliteCHEBI:35457 (ChEBI)
ACE2GeneProduct509235 (Entrez Gene)
ACEGeneProduct509484 (Entrez Gene)
AGTGeneProduct
AGTR1GeneProduct281607 (Entrez Gene)
AGTR2GeneProduct407157 (Entrez Gene)
ATP6AP2GeneProduct513520 (Entrez Gene)
AldosteroneMetaboliteHMDB00037 (HMDB)
Ang 1-5MetaboliteC15852 (KEGG Compound)
Ang 1-7Metabolite110354 (Chemspider)
Ang 1-9MetaboliteC15851 (KEGG Compound)
Angiotensin IMetabolite3081372 (PubChem-compound)
Angiotensin IIMetaboliteHMDB01035 (HMDB)
BDKRB1GeneProduct532119 (Entrez Gene)
BDKRB2GeneProduct538896 (Entrez Gene)
BradykininMetaboliteHMDB04246 (HMDB)
CMA1GeneProduct
CTSGGeneProduct
CYP11B1GeneProduct282422 (Entrez Gene)
Ca++MetaboliteHMDB00464 (HMDB)
DeoxycorticosteroneMetaboliteHMDB00016 (HMDB)
KNG1GeneProduct280833 (Entrez Gene)
MAS1GeneProduct783010 (Entrez Gene)
NOS3GeneProduct287024 (Entrez Gene)
NR3C2GeneProduct537614 (Entrez Gene)
ProstacyclinMetabolite114805 (PubChem-compound)
RENGeneProduct280909 (Entrez Gene)
TFsGeneProduct
TGFB1GeneProduct282089 (Entrez Gene)

Annotated Interactions

No annotated interactions
Retrieved from "https://classic.wikipathways.org/index.php/Pathway:WP1033"
Personal tools